Lyfgenia Suspension
Product Images NDC 73554-1111

3 FDA label images from Genetix Biotherapeutics Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lyfgenia (NDC 73554-1111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genetix Biotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mL Bag Patient Identifier Label)

Principal Display Panel (20 mL Bag Patient Identifier Label)
Label for Lyfgenia (lovotibeglogene autotemcel) suspension for intravenous infusion. The label indicates a 20 mL volume containing 1.7 to 20 million cells per mL (including CD34+ cells). It features a section to confirm patient identifiers such as name, date of birth, patient ID, COI ID, lot number, expiration date, bag number, and DIN numbers. The label includes the Genetix Biotherapeutics logo and U.S. license number 2425.*
FDA Label Image

Principal Display Panel (20 mL Bag Label)

Principal Display Panel (20 mL Bag Label)
Lyfgenia (lovotibeglogene autotemcel) suspension for intravenous infusion. The label specifies a concentration of 20 mL containing 1.7 to 20 x 10^6 cells/mL, including CD34+ cells. It is for autologous use only and contains genetically modified autologous hematopoietic stem cells in a cryopreservation solution with 5% DMSO. Manufactured for Genetix Biotherapeutics Inc., Somerville, MA.*
FDA Label Image

Principal Display Panel (20 mL Bag Cassette Label)

Principal Display Panel (20 mL Bag Cassette Label)
Label for Lyfgenia (lovotibeglogene autotemcel) suspension for intravenous infusion, 20 mL containing 1.7 to 20 x 10^6 cells/mL. The label includes warnings for autologous use only, storage instructions in vapor phase liquid nitrogen, and directions to confirm patient identifiers. The labeler is Genetix Biotherapeutics Inc., with manufacturer bluebird bio, Inc., and a barcode is present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.